Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
| 5 Sep 2025 | |
| General |
By Mark Meyocks, Founder/CEO at MyWay MSK
Joint pain and discomfort are the human body’s alarm system for Musculoskeletal (MSK) care attention. MSK care is the largest cost driver of medical care for working-age Americans today.
Through 2023, the National Institute of Health reports:
Forty percent of insured adults sought MSK care in 2023, with direct billed care costs averaging $7,000-$9,000 per individual, not including the aforementioned workday and productivity losses. However, averages can be deceiving.
Direct MSK claims data analysis indicates that less than 5% of participants spend 85% of plan sponsor MSK care dollars on injections, imaging, and surgeries. These are mostly workforce plan participants aged 50-65, seeking medical care for advanced chronic MSK conditions developed over years of inattention.
But one third of the United States population is 20-45 years old, and this next generation of workers’ MSK care alarms are awakening, with over 15% reporting chronic MSK pain today. How do decision makers of plan sponsors prepare? How are younger participants avoiding this same MSK future affecting older participants today?
In theory, convenient participant-centric value-based care benefits the participant, employer, and plan sponsor. Quick therapy delivery directly impacts MSK health outcomes while reducing costs, and goes beyond theory.
Welcome to MyWay MSK. Participant-centric value-based musculoskeletal care to commandeer MSK care delivery in the United States, with our patent-pending ‘Musculoskeletal Care Delivery Savings Strategy.’
Uniquely designed to deliver joint-specific care to the participant in less than 4 minutes. MyWay MSK provides therapeutics developed over eons, supported by the best of today’s orthopedic advances, that achieve immediate MSK care delivered to participants–not in hours, days, or weeks, but now, for immediate participant relief.
Providing access to MSK care therapeutics when needed by participants immediately saves care costs down the road. Combining MyWay MSK processes: self-care therapy, advanced ‘ProStaff’ (Disabled Veteran) guidance, and medical clinician review, improves in-network MSK therapeutic outcomes, in a HIPAA-compliant environment, without plan design changes. There is no more effective access to MSK care for participants available today.
Contact us to learn more about decreasing your organization’s MSK funding costs and improving participant health through MyWay MSK care access and delivery.
